Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 316 followers
Latest posts
Last updated 34 minutes ago
Harmony halts genetic disease program following phase 3 Fragile X failure
34 minutes ago
After its cannabidiol gel candidate failed a phase 3 trial in fragile...
Publisher’s note: Questex acquisition supercharges Fierce portfolio with The Conference Forum, Versalinx Global Events
about 1 hour ago
Questex has acquired The Conference Forum and Versalinx Global Events, two highly...
Novo, Pfizer’s bidding war heats up with supercharged offers for Metsera
about 3 hours ago
Pfizer may have launched a multi-front legal battle to prevent Metsera from...
Prelude loses CMO, pauses SMARCA2 degraders and bags $60M from Incyte
about 4 hours ago
The precision oncology biotech is pausing work on SMARCA2 degraders and selling...
Sarepta pushes for full approval of Duchenne drugs despite missed confirmatory trial goal
about 4 hours ago
A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy...
Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset
about 4 hours ago
Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to...
Olympus updates corrective action related to 2023 lung scope recall
about 5 hours ago
Olympus has issued updated corrective action related to the 2023 recall of...
Boehringer Ingelheim's deal frenzy continues with $570M autoimmune pact
about 5 hours ago
Boehringer Ingelheim’s busy year of dealmaking is showing no signs of slowing...
New in vivo cell therapy biotech blossoms from CRISPR pioneer Doudna’s lab with $82M
about 5 hours ago
A new West Coast biotech has emerged into the busy in vivo...
Nuvation cancels plans to test brain cancer drug directly against Voranigo on FDA's advice
about 6 hours ago
Nuvation Bio has backed off from its plans to directly compare its...
ABL spinout Neok exits stealth with $75M to take bispecific ADCs into the clinic
about 6 hours ago
Neok Bio has exited stealth with $75 million to take a pair...
Celltrion looks beyond biosimilars with $744M pact for 2 preclinical autoimmune drugs
about 7 hours ago
Korean biosimilar specialist Celltrion has penned a deal worth more than $740...